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Foreign bodies made of polymethylmethacrylate coverslips were implanted subcutane-
ously into guinea pigs, were explanted four weeks later, and were tested for in vitro ad-
herence of Staphylococcus aureus strain Wood 46. In the presence of serum, the level
of staphylococcal adherence to explanted coverslips was 20 times higher than that of ad-
herence to unimplanted coverslips. Adherence to explanted coverslips was caused by
fibronectin deposits on the foreign body surface and was inhibited in a dose-related
fashion by specific antibodies to fibronectin.
Implantation of prostheses and insertion of
catheters into humans are associated with an en-
hanced risk of bacterial infection in the immediate
vicinity of the synthetic foreign material; when
such infection develops it compromises the func-
tion of the prosthesis or catheter [1-4]. In animal
models foreign body infections have been pro-
voked by 102 cfu of Staphylococcus aureus,
whereas even 106 bacteria have failed to cause in-
fection in the absence of foreign material [5-7].
Foreign body infections are not cured by an-
timicrobial treatments that are considered to be ef-
fective in the absence of foreign material [1-4].
This observation has led to the assumption that
the synthetic material creates a microenvironment
that favors bacterial multiplication and reduces ac-
cessibility to antibiotics [8]. Ultrastructural studies
of the surface of pacemakers and catheters re-
moved from humans have indeed revealed exten-
sive growth of bacterial microcolonies embedded
in a thick matrix of polysaccharides [9, 10]; this
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matrix is probably of bacterial origin. A number
of other studies have documented the immediate
formation of a conditioning layer of host proteins
on the surface of various synthetic materials ex-
posed to blood proteins [11, 12]. Such protein
layers are known to affect the subsequent adsorp-
tion of microorganisms on a variety of natural or
artificial substrates [13, 14]. Therefore, these pro-
tein layers may control bacterial attachment during
foreign body infection.
We previously developed an experimental model
of foreign body infection [15] by implanting poly-
methylmethacrylate (MTA, Plexiglass) "tissue
cages" sc into guinea pigs and then infecting the
animals with 103 cfu of S. aureus strain Wood 46,
which is devoid of protein A [16]. In the present
study of bacterial adherence to MTA, we placed
MTA coverslips inside tissue cages. Using an in
vitro assay for the measurement of adherence of
S. aureus strain Wood 46 to MTA coverslips, we
compared the adhesive properties of explanted
coverslips with those of unimplanted coverslips.
We found evidence that fibronectin, which is
deposited on the coverslips after their sc implanta-
tion, is a major determinant of adherence of
S. aureus strain Wood 46.
Materials and Methods
Implantation ofMTA coverslips into guinea pigs.
MTA coverslips (l x 1 ern, ethanol-cleaned) were
inserted into rigid MTA tissue cages, which were
then sterilized and implanted sc into guinea pigs
[15]. After four weeks the tissue cages were ex-
planted under anesthesia [15] and opened at both
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Figure 1. SDS-PAGE of purifiedfibronectin on a dis-
continuous slab gel. A gradient gel was made (5070-15%
in acrylamide), and the samples were tested under reduc-
ing conditions. Lane A shows the results obtained with
4 JAg of purified human fibronectin, and lane B shows
those obtained with molecular weight standard (myosin,
f3-galactosidase, phosphorylase D, bovine serum albumin,
ovalbumin).
fibronectin was measured spectrophotometrically
by use of an absorbance value of 1.28 at 280 nm
[21]. Fibronectin was also measured with the
fibronectin turbidimetric immunoassay from
Boehringer (Mannheim, Federal Republic of Ger-
many) and was found to be active in a macrophage
phagocytic assay [22].
Fibrinogen was prepared from a cryoprecipitate
of pooled human plasma, which was extracted
twice with a buffer containing 10070 ethanol. The
unextracted material (containing fibrinogen) was
then solubilized in citrate-glycine buffer and freed
from particulate material by centrifugation at
2,000 g for 20 min. The supernatant was stored in
lyophilized form and then dissolved again in
buffer and freed from fibronectin by three pas-
sages over a gelatin-Sepharose column [17]. This
preparation contained 5 mg of protein/ml, with <2
lAg of fibronectin/ml (as determined with the
aforementioned turbidimetric immunoassay).
Preparation of monospecific antibodies to
ends for removal of the coverslips, which were
rinsed twice in PBS before being used in the adher-
ence assay.
Assay for adherence of S. aureus strain Wood
46. A total of 2 x 107 cfu of S. aureus strain
Wood 46 were incubated with 100 IACi of [methyl-
"Hlthymidine in 1 ml of Mueller-Hinton broth for
3 hr at 37 C and were grown to a concentration of
1-2 x 108 cfu/ml. After removal of the unbound
radioactivity by centrifugation, the radiolabeled
strain was suspended in 1 ml of 0.15 M NaCI (sa-
line). Thereafter, aliquots of S. aureus in 1 ml of
the selected attachment medium were incubated
with either unimplanted or explanted MTA cover-
slips at 37 C with agitation. At the end of the at-
tachment period, the fluids containing unbound
bacteria were drained, and the coverslips were
transferred into new tubes containing 1 ml of sa-
line. This transfer procedure minimized the carry-
over of fluid contaminated by unbound bacteria.
After incubation for 5 min at 20 C, a second wash
was performed with 1 ml of fresh saline for 30 min
at 20 C. Finally, the coverslips were transferred into
new tubes containing 1 ml of PBS and were in-
cubated for another 30 min at 37°C with agitation.
This last procedure released <20% of the bacteria
from the coverslips. Thereafter, drained slides were
immersed into scintillation fluid (Dimilume";
Packard Instruments, Houston), and their radioac-
tivity was counted in a liquid scintillation counter
(model no. LS-3145 T; Beckman Instruments,
Fullerton, Calif). The cpm values were then multi-
plied by the cfu/cpm ratio of the radiolabeled cul-
ture of S. aureus strain Wood 46 (average ratio, 43
± 14cfu/cpm; 40 experiments). This procedure al-
lowed the quantification of the bacteria adherent
to the coverslips.
Purification of human fibronectin and fibrino-
gen. Fibronectin was purified from pooled hu-
man plasma by affinity chromatography on gela-
tin-Sepharose 4B (Pharmacia Fine Chemicals,
Piscataway, NJ) [17]. Plasma proteins that bound
nonspecifically to the matrix were first removed
with a column packed with unmodified Sepharose
[18]. Plasma proteins that were weakly bound to
the gelatin-Sepharose were washed off with 1 M
urea. Thereafter, fibronectin was eluted with 4 M
urea, concentrated by ultrafiltration, and stored as
described previously [19]. Purified fibronectin was
shown to be free of contaminants by SDS-PAGE
[20] (figure 1). The concentration of the purified
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Figure 2. Adherence of S. aureus strain Wood 46 to
unimplanted MTA coverslips. Concentrations of lOS
cfu/ml (..6.), 106 cfu/ml (A), 4 X 106 cfu/ml (0), and 107
cfu/ml (.) were incubated with coverslips for periods of
30 sec to 120 min in 1 ml of D-PBS (attachment phase),
and the adherence assay was performed as described in
Materials and Methods. The values shown are means
(± SE) obtained in four experiments.
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mg of serum albumin/ml (PBS-HSA). Control
coverslips, whether coated with fibronectin or ex-
planted, were incubated in parallel in PBS-HSA in
the absence of immunoglobulins. Control and
immunoglobulin-treated coverslips were rinsed in
PBS before being tested in the adherence assay.
Immunofluorescence microscopy. Coverslips
freshly explanted from guinea pigs were rinsed and
directly incubated for 30 min at 20 C with 32 ug of
anti-FN IgG/ml of PBS-HSA. After extensive rins-
ing in PBS-HSA, coverslips were mounted on
glass slides in Eukitt (Gribi, Bern, Switzerland)
and were incubated for a further 30 min with
fluorescein-conjugated goat antibody to rabbit
IgG (Miles Yeda, Rehovot, Israel) diluted 1:20 in
PBS. After extensive rinsing in PBS, coverslips
were examined with a microscope (Photomicro-
scope nI®; Carl Zeiss Instruments, New York).
Photographs were taken with Plus-X'" film (East-
man Kodak, Rochester, NY) that was developed at
ASA 400 with Diafine'" (Eastman Kodak).
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fibronectin. Rabbit antibodies to human fibro-
nectin were prepared essentially according to Zardi
et al. [18]. Antiserum from immunized rabbits was
adsorbed onto insolubilized fibronectin-free plas-
ma proteins [18] and was shown to be monospeci-
fie by immunoelectrophoresis. The following im-
munoglobulin fractions were obtained from the
monospecific antiserum by ammonium sulfate
precipitation: (1) total immunoglobulins (IgG); (2)
inimunoglobulins depleted of antifibronectin ac-
tivity, which were designated dIgG and were ob-
tained after selective removal of antibodies to
fibronectin by affinity chromatography on im-
mobilized fibronectin; and (3) affinity-purified an-
tibodies to fibronectin, which were designated
anti-FN IgG and were obtained by elution of the
immunoglobulins previously adsorbed on the
fibronectin-Sepharose gel. After weakly binding
antibodies had been removed with 3 M KSCN,
affinity-purified anti-FN IgG was eluted from the
column with 8 M urea.
Modification of S. aureus adherence to cover-
slips. All adherence assays were performed in
Dulbecco's PBS solution supplemented with 1 roM
caci, and 0.5 roM MgS04 (D-PBS; Gibco, Bio-
Cutt, Glasgow, Scotland). When serum, plasma,
or albumin from humans or guinea pigs was in-
cluded in the attachment-phase medium, the pro-
tein concentration was adjusted to 5 mg/ml of
D-PBS.
Unimplanted coverslips were treated with pro-
tein solutions according to the experimental pro-
tocol and were rinsed in PBS before the adherence
assay. Unimplanted coverslips were coated with
purified fibronectin by incubation for 1 hr at 37 C
in a solution containing 125 Ilg of fibronectin/ml
of PBS and subsequent rinsing in PBS.
Some explanted coverslips were trypsinized be-
fore the adherence assay by incubation for 20 min
at 37 C in 1 ml of a solution containing 10 Ilg of
purified trypsin/ml (Sigma Chemical, St. Louis).
Thereafter, soybean trypsin inhibitor (Sigma) was
added to a 10-fold excess concentration, and
coverslips were finally rinsed in PBS.
In other experiments fibronectin-coated or ex-
planted coverslips were treated before the adher-
ence assay with one of the three immunoglobulin
fractions prepared from antiserum to fibronectin.
Both types of coverslips were incubated for 30 min
at 37 C with solutions of immunoglobulins at vari-
ous concentrations in PBS supplemented with 5
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Table 1. Influence of serum, plasma, interstitial "tissue-
cage" fluid, purified albumin, and coverslip trypsinization
on the adherence of S. aureus strain Wood 46 to un-
implanted and explanted MT A coverslips.
NOTE. Each adherence assay was performed with a single
inoculum of 4 x 106 cfu of S. aureus strain Wood 46/ml of
D-PBS supplemented with the indicated protein sources (protein
concentration, 5 mg/ml).
* Data are means ± SE values, with the number of experi-
ments indicated in parentheses. ND = not done.
t p < .001 vs. results obtained with indentically treated,
unimplanted coverslips (Student's two-tailed t test).
+P < .01 vs. results obtained with albumin-treated, untryp-
sinized coverslips (Student's two-tailed t test).
in D-PBS, inhibited the adherence of S. aureus
strain Wood 46 by 90%. Thus, virtually no binding
sites for S. aureus were left on unimplanted MTA
coverslips after exposure to serum, tissue-cage
fluid, or albumin.
Explanted coverslips showed modified adher-
ence properties with regard to S. aureus strain
Wood 46 (table 1). In the presence of human albu-
min or of serum or tissue-cage fluid from guinea
pigs, explanted coverslips bound 15-20 times more
bacteria than did unimplanted coverslips (P
< .001). This enhanced adherence to explanted
coverslips was reduced by 84UJo when the coverslips
were pretreated with trypsin.
Microscopic examination revealed that ex-
planted coverslips were coated with fibers and cel-
lular materials that stained intensely with 32 Mg of
anti-FN IgG/ml (figure 3); staining was not ob-
served after incubation of coverslips with dIgG or
with preimmune rabbit IgG at concentrations as
high as 500 ug/rnl (data not shown). In addition,
no staining was observed after incubation with pu-
rified fluorescein isothiocyanate-Iabeled antibody
25 ± 10+ (3)
Explanted
155 ± 70t (7)
NO
NO
NO
210 ± 35t (4)
190 ± 40t (7)
NO
9 ± 2 (16)
8 ± 2 (15)
Unimplanted
1,590 ± 110 (46)
4 ± 2 (6)
6 ± 3 (4)
10 ± 4 (5)
No. of staphylococci (cfu x 102)
adherent to indicated type of coverslip*
Treatment of
incubation mixture
None
Human serum
Human plasma
Guinea pig serum
Guinea pig tissue-
cage fluid
Human albumin
Untrypsinized
coverslips
Trypsinized
coverslips
Figure 3. Immunofluorescent staining of explanted
MTA coverslips for fibronectin with affinity-purified
anti-FN IgG (32 JAg/ml). The staining procedure is detailed
in Materials and Methods.
Results
Figure 2 shows how various incubation periods
and bacterial concentrations influenced the adher-
ence of S. aureus strain Wood 46 to unimplanted
MTA coverslips in D-PBS medium. On the basis of
these data, we selected a single bacterial concentra-
tion (4 X 106 cfu/ml) and incubation period (60
min) for use in all further assays involving unim-
planted and explanted coverslips. An increase in
coverslip area by a factor of two, three, or four
resulted in an increase in the adherence of
S. aureus strain Wood 46 by a factor of 2.09 ±
0.08, 3.04 ± 0.19, or 4.45 ± 0.34, respectively
(mean ± SE; three experiments). All further ad-
herence assays were performed with a single
coverslip area (1 X 1 em),
The presence of serum proteins at a concentra-
tion of 5 mg/ml had a striking effect on the adher-
ence of S. aureus strain Wood 46 to unimplanted
coverslips. Table 1 shows that <103 bacteria at-
tached to MTA in the presence of human or guinea
pig serum, human plasma, purified human serum
albumin, or guinea pig "tissue-cage" fluid [15].
These results represented inhibition of adherence
by >99070 in comparison with adherence to unim-
planted coverslips in buffer alone. Lower serum or
albumin concentrations also inhibited the adher-
ence of S. aureus strain Wood 46, with inhibition
by 50070 at a concentration of 0.02 mg of pro-
tein/rnl. Preincubation of MTA coverslips with se-
rum, albumin, or tissue-cage fluid at a protein con-
centration of ~ 0.05 mg/ml, followed by washing
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to fibrinogen at a concentration of 500 ug/ml
(Nordic Immunological Laboratory, Tilburg, The
Netherlands; data not shown).
To demonstrate that fibronectin deposited on
MTA coverslips during in vivo exposure was a ma-
jor factor mediating the adherence of S. aureus
strain Wood 46 to the coverslips, we tried to block
binding sites with specific antibodies to fibronec-
tin. This approach is feasible with S. aureus strain
Wood 46, which is devoid of protein A and does
not attach nonspecifically to IgO by its Fe portion
[16]. Inhibition of the adherence of S. aureus strain
Wood 46 by antibodies to fibronectin was studied
first on unimplanted MTA coverslips coated in
vitro with fibronectin. Recent studies by other in-
vestigators [23] and by our group [23a] have shown
that either fibronectin-coated tissue-culture wells
[23] or fibronectin-coated MTA coverslips can pro-
mote the adherence of S. aureus in the presence of
5 mg of human albumin/ml of buffer solution.
Under our experimental conditions fibronectin-
coated coverslips bound 7.72 X 104 ± 1.58 X 104
cfu (mean ± SE; four experiments) of S. aureus
strain Wood 46 from an initial suspension of 4 X
106 cfu/ml during incubation for 60 min at 37 C.
No adherence «103 cfu/ml) was observed after ei-
ther heating of the fibronectin (5 min, 90 C) or
trypsinization of the fibronectin-coated coverslips
(authors' unpublished observations). When fibro-
nectin-coated coverslips were treated with antibod-
ies to fibronectin before the adherence assay, the
adherence of S. aureus strain Wood 46 was in-
hibited in a dose-related fashion (figure 4, graph
A). The specificity of this inhibitory effect was
shown as follows. First, when antibodies to
fibronectin were removed from the immunoglobu-
lin fraction by affinity chromatography on
fibronectin-Sepharose, the resulting dIgO did not
inhibit the adherence of S. aureus (figure 4, graph
A). Second, elution of antibody to fibronectin
from the fibronectin-Sepharose column led to the
recovery of the fraction inhibiting the adherence of
S. aureus strain Wood 46 (anti-FN IgO), which
showed an even higher specific activity (figure 4,
graph A.)
When antibodies to fibronectin were added to
explanted coverslips, the adherence of S. aureus
strain Wood 46 was again inhibited in a dose-
related manner (figure 4, graph B); the degree of
inhibition reached 80% after pretreatment of ex-
planted coverslips with 32 Ilg of anti-FN IgO/ml.
The adherence of S. aureus strain Wood 46 to ex-
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Figure 4. Inhibition of the adherence of S. aureusstrain
Wood 46 to fibronectin-coated, unimplanted MTA cover-
slips (A) and explanted coverslips (B) by antibodies to
fibronectin. Immunoglobulins from sera of rabbits
immunized against fibronectin (0), dIgG from the same
sera (e), or anti-FN IgG (.) was applied to the coverslips.
After rinsing, the adherence assay was performed as
described in Materials and Methods in the presence of
5 mg of human serum albumin/ml, which was added to
D-PBS during the attachment phase. The values shown
are means (± SE) obtained in four experiments.
planted coverslips was not inhibited by dIgO (fig-
ure 4, graph B). Thus, the fibronectin deposited on
MTA coverslips during their implantation into
guinea pigs appeared to be a major factor in the
binding of S. aureus strain Wood 46 to this foreign
material.
To exclude the possibility that traces of antibod-
ies to an antigen other than fibronectin were con-
tributing significantly to the inhibition of bacterial
adherence, we did the following control experi-
ments. (1) The preparation of anti-FN IgO was fur-
ther purified of possible antibodies to fibrinogen
in undetected trace amounts by chromatography
on immobilized purified fibrinogen showing
<0.05 % contamination with fibronectin. After
removal of the antibodies to fibrinogen by affinity
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chromatography, anti-FN IgG was still inhibitory
to S. aureus strain Wood 46 on unimplanted,
fibronectin-coated coverslips or on explanted
coverslips. Furthermore, the potency of anti-FN
IgG was not modified after its incubation with im-
mobilized fibrinogen, since the dose-response
curves of the antibody's inhibitory effect on bac-
terial adherence could be superimposed on those
shown in figure 4 (data not shown). (2) Unim-
planted MTA coverslips coated with purified
fibrinogen (from a solution containing 500 JAg of
protein/ml) were found to bind S. aureus strain
Wood 46 rather poorly (6 X 103 cfu) in the pres-
ence of human albumin in the adherence assay. A
similarly low level of adherence was recorded on
MTA coverslips precoated with denatured collagen
[23a]. (3) Unimplanted MTA coverslips coated
with fibrinogen were found to be unaffected by the
presence of anti-FN IgG in the adherence assay. (4)
The presence of purified fibrinogen (500 ug/ml) in
the assay of adherence to fibronectin-coated MTA
coverslips was found to have no stimulatory or in-
hibitory effect on bacterial adherence [23a]. These
data made unlikely the contribution of trace
amounts of fibrinogen to the process of adherence
to fibronectin-coated MTA coverslips.
Discussion
Fibronectin is a multifunctional glycoprotein
found either in connective tissues and basement
membranes or in a more soluble form in plasma
and other body fluids [24, 25]. The binding of
fibronectin to S. aureus has been described in a
number of reports [26-28], although the func-
tional significance of this event is still a matter of
controversy [29-31]. Our studies suggest that
fibronectin may be an important mediator of bac-
terial adherence and thus may contribute to the
pathogenesis of foreign body infection.
A wide array of blood and tissue proteins may
interact with either S. aureus [16, 23, 26-34] or im-
planted synthetic material [11, 12]. Our experimen-
tal approach, which involved the use of specific an-
tibodies, allowed us to study the contribution of
fibronectin to bacterial adherence under complex
conditions that approximated the in vivo situation.
Our study was also facilitated by the fact that bac-
terial adherence to MTA coverslips devoid of ad-
sorbed fibronectin was negligible in albumin-
containing media. Vercelloti et al. [23] recently
reported similar findings with regard to a different
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kind of plastic surface: hydrophilic tissue-culture
wells.
In a separate study [23a] we defined the ex-
perimental conditions that allowed the adsorption
of fibronectin onto MTA coverslips. Such adsorp-
tion did not occur on the smooth plastic surface in
the presence of human serum proteins, as rep-
resented by a fibronectin-depleted pool. In con-
trast, precoating of MTA with denatured collagen
resulted in a significant level of adsorption of
fibronectin onto MTA coverslips, even in the pres-
ence of serum proteins.
In the present study the choice of S. aureus
strain Wood 46, which is poorly virulent to hu-
mans, was motivated by the lack of protein A on
the surface of this organism [16]; this characteristic
prevents nonspecific binding to the various im-
munoglobulin fractions used in this study. The fact
that this strain can cause infections when as-
sociated with a foreign body has been well
documented [15]. As far as we know, this is the
first report of inhibition of fibronectin-mediated
binding of a microorganism by antibodies to
fibronectin. A previous attempt to block the bind-
ing of fibronectin and a protein A-positive strain
of S. aureus with Ftab'), fragments of antibodies
to fibronectin was unsuccessful [26]. It should be
stressed, however, that other fibronectin-mediated
functions, such as fibroblast attachment to sub-
strates [35] or fibronectin binding to gelatin [36],
can be blocked by antibodies to fibronectin.
At least two types of fibronectin - plasma and
cellular f24] - are structurally and functionally
similar, although not identical. Monoclonal anti-
bodies have been found that bind preferentially to
cellular rather than to plasma fibronectin [24].
MTA coverslips explanted from guinea pigs may
contain these different types of fibronectin, and
both types may contribute to the adherence of
S. aureusstrain Wood 46, although the relative im-
portance of their contributions remains unknown.
Microscopic observation of S. aureus strain Wood
46 organisms stained with acridine orange after
their attachment to explanted coverslips has shown
these organisms to be preferentially located on
fibronectin-positive fibers (authors' unpublished
observations). That such a fibrillar network may
include other macromolecular components (such
as collagen and sulfated proteoglycans) codis-
tributed with fibronectin is suggested by other
studies of the pericellular matrix of connective tis-
sue [37]. Further studies of the interaction of
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S. aureus strain Wood 46 with fibronectin located
on the fibrillar network of explanted coverslips
will need to include a consideration of the possible
contribution of collagen and proteoglycans to
fibronectin-mediated attachment. The authors of
recent reports [23, 32, 33] have stressed the role of
tissue-bound fibronectin as an important ligand of
S. aureus that promotes the development of vari-
ous types of staphylococcal infections.
Although in the present report we have identi-
fied fibronectin as the surface protein involved in
the adherence of S. aureus to explanted coverslips,
the other component of such interations - namely,
the bacterial adhesin - has yet to be defined for
staphylococcal strain Wood 46. We found no
difference in bacterial adherence to explanted
coverslips when S. aureus strain Wood 46 was in-
cubated with liquids varying in their protein com-
position, such as serum, interstitial fluid, or puri-
fied albumin (table 1). Such data do not exclude
the possibility that other purified blood fractions
interacting mainly with the bacterial surface may
modulate the subsequent adherence of S. aureus to
explanted coverslips. The possible interference of
soluble fibronectin with the adherence of S. aureus
to surface-bound fibronectin was recently consid-
ered [23]. Surprisingly, S. aureus pretreated with
purified soluble fibronectin showed an enhanced
ability to adhere to the fibronectin of endothelial
cells [23]. These data may be the result of bacterial
clumping induced by fibronectin or may reflect
other, more complex processes.
In conclusion, our studies have demonstrated
that fibronectin is deposited on the surface of a
foreign body implanted in an animal. This
deposited fibronectin plays an important role in
the attachment of S. aureus strain Wood 46 to the
foreign material. It remains to be established
whether our observation is restricted to the type of
material studied and the experimental system
selected or whether it applies to other types of
prosthetic devices, including those widely used in
various clinical situations.
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